BRIEF published on 09/18/2025 at 07:35, 10 months 22 days ago Nexity Initiates Share Buyback Program Share Buyback Employee Ownership Urban Development Nexity Low-Carbon Construction
BRIEF published on 09/18/2025 at 07:35, 10 months 22 days ago Nexity lance un programme de rachat d'actions Rachat D'actions Actionnariat Salarié Développement Urbain Nexity Construction À Faible Émission De Carbone
PRESS RELEASE published on 09/18/2025 at 07:30, 10 months 22 days ago Implementation of a share buyback program Nexity announces the implementation of a share buyback program to allocate 200,000 shares for employee share plans. The program aims to support urban regeneration and sustainable housing initiatives Share Buyback Program Sustainable Housing Nexity Employee Share Plans Urban Regeneration
PRESS RELEASE published on 09/18/2025 at 07:30, 10 months 22 days ago Mise en œuvre d'un programme de rachat d'actions Nexity annonce la mise en œuvre d'un programme de rachat d'actions pour un montant maximum de 200 000 actions, destinées à couvrir des plans d'actions gratuites Rachat D'actions Actionnaires Assemblée Générale Programme De Rachat Nexity
PRESS RELEASE published on 07/08/2025 at 15:12, 1 year 1 month ago Modalité de mise à disposition des documents préparatoires à l'AG
BRIEF published on 03/03/2025 at 21:47, 1 year 5 months ago NEXITY : Déclaration des droits de vote et des actions au 31/02/2025 Actions Transparence Droit De Vote Nexité Février 2025
BRIEF published on 03/03/2025 at 21:47, 1 year 5 months ago NEXITY: February 2025 Voting Rights and Share Disclosure Voting Rights Shares Transparency Nexity February 2025
PRESS RELEASE published on 03/03/2025 at 21:42, 1 year 5 months ago Nexity Nombre total d'actions et droit de vote composant le capital - Février 2025 Nexity communique le nombre total d'actions et de droits de vote au 28 février 2025 conformément aux règlements de l'AMF et du Code de commerce Droits De Vote Code De Commerce Actions AMF Nexity
PRESS RELEASE published on 03/03/2025 at 21:42, 1 year 5 months ago Monthly disclosure of the total number of voting rights and shares - February 2025 Nexity discloses monthly total voting rights and shares. Total shares: 56,129,724. Net voting rights: 55,748,723 Share Capital Voting Rights Financial Markets Monthly Disclosure Nexity
BRIEF published on 07/08/2024 at 09:13, 2 years 1 month ago NEXITY: End of Concert Action and Crossing of Thresholds Reorganization Crossing Thresholds Nexity Concert Action Crédit Mutuel Arkéa
Published on 08/10/2026 at 08:00, 2 hours 8 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 8 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 18 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 7 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 7 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 8 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 45 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 45 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 8 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 8 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
